Dallah Healthcare says talks to buy stake in associate firm end without agreement

17/01/2023 Argaam
Logo ofDallah Healthcare Co.

Logo of Dallah Healthcare Co.

Dallah Healthcare Co. (DHC) announced that negotiations with the selling shareholders of Dr Mohammad bin Rashed Al Faqih & Partners Co. to purchase all their shares terminated without an agreement. 

 

In a statement to Tadawul, DHC said that the proposed deal will not be completed this time, adding that there is no financial impact from the termination of negotiations.

 

On Sept. 18, 2022, DHC board of directors decided to start negotiations with shareholders selling their stake of 68.79%, or 34.395 million shares, in Dr Mohammad bin Rashed Al Faqih & Partners Co., Argaam earlier reported.

 

 

For More Mergers and Acquisitions

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.